Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ: CMPS )

32.22 -0.08 (-0.25%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2 3 4 5 6 7 Next >
Why An ATAI IPO Is Driving MindMed Stock
ATAI Life Sciences has announced its going public in Spring 2021. MindMed Inc has exploded on this news. Find out why the two events are connected. 
From TalkMarkets
Psychedelic Drug Stock's Biggest Investor Closes $125 Million Funding Round
Atai Life Sciences, a company that backs Compass Pathways (CMPS) and other psychedelic drug developers, said Monday that it had closed a $125 million funding round, the latest infusion for an industry... 
From Investor's Business Daily
The New Psychedelic Stocks Index Declined 5.4% This Past Week
This article tracks the weekly performance of 11 of 31 stocks involved in the research and development of psychedelic compounds to treat mental health issues such as OCD, PTSD, opioid and alcohol... 
From TalkMarkets
Is Compass Pathways Stock a Buy?
Oregon just decriminalized the use of the psychedelic compound psilocybin. Could Compass Pathways, which is testing a synthetic form of the drug as a mental health therapy, be on the cusp of something... 
From Motley Fool
Psychedelic "Health" Stocks Outperformed Cannabis "Health" Stocks Last Week
The average performance of the 11 constituents in the Pure-Play Psychedelic Stocks Index was +2.5% last week (+14.5% the previous week) out-performing the 1.8% increase in the Pure-Play Pot Stock Index... 
From TalkMarkets
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
Welcome to theCannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock ... 
From Benzinga
Psyched: CA Discusses Decriminalization, Compass Holds Earnings Call, Psychedelics Hotline To Launch
California’s legislature could soon be discussing a new bill meant to decriminalize psychedelic substances. On Tuesday, State ... 
From Benzinga
Psychedelic Drug IPO Reports Wider Losses But Holds View On Key Data
Compass Pathways reported deeper Q3 losses but maintained its view that data from a clinical trial will come next year. 
From Investor's Business Daily
Earnings Scheduled For November 12, 2020
Companies Reporting Before The Bell • Redhill Biopharma (NASDAQ:RDHL) is projected to report quarterly loss at $0.16 ... 
From Benzinga
A Market Reality Check For Psychedelic Stocks
The Psychedelics Revolution is here to stay. The solutions of tomorrow are the investments of today. 
From TalkMarkets
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
Welcome to theCannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock ... 
From Benzinga
New Psychedelic Stocks: The Menu Is Getting Longer For Investors
Three new psychedelic stocks are trading publicly. One commenced trading last week, two more are coming this week. 
From TalkMarkets
12 Healthcare Stocks Moving In Wednesday's After-Market Session
Gainers Synlogic (NASDAQ:SYBX) stock increased by 10.1% to $2.07 during Wednesday's after-market session. Trading volume for this ... 
From Benzinga
Could These 4 Biotech & Psychedelic Stocks See Bullish Interest in 2020?
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
What Oregon Psilocybin Legalization Means For The Psychedelic Drug Industry
We explain why psychedelic drug stocks are surging on news that Oregon has legalized psilocybin for medicinal use. 
From TalkMarkets
Psychedelic Drug Stock Jumps After State Ballot Legalizes Therapy
Compass Pathways rallied after Oregon legalized psilocybin therapy and Washington, D.C., decriminalized the hallucinogenic substance. 
From Investor's Business Daily
Medicinal Mushroom Stock Index: Performance Hardly "Magical" Last Week
Research into the use of mushrooms in the treatment of mental health issues (PTSD, opioid/alcohol addiction, depression, anxiety, eating disorders) suggests that the medicinal mushroom industry is... 
From TalkMarkets
Psyched: St. Vincent OKs Psychedelics Program, Delic To Go Public, Field Trip Drug Update
Saint Vincent Okays Psychedelic Initiative The Caribbean country of Saint Vincent and the Grenadines has approved an initiative to ... 
From Benzinga
Medicinal Mushroom Stocks Made Major Move Down On Wednesday And Thursday
Treatment of a host of mental issues using magic​​​ mushrooms is on the threshold of becoming the next billion-dollar industry. The industry is in its infancy with 12 companies, as identified below,... 
From TalkMarkets
Volatility Reigns In New Medicinal Mushroom Stocks Index
​​​​​​​Treatment of depression, anxiety, and addiction health issues using either functional (i.e. edible) or psychedelic (i.e. magic) mushrooms could become the next billion-dollar industry and this... 
From TalkMarkets
The 4 Best-Performing Psychedelic Stocks
As the new rally in psychedelic stocks progresses, these four companies are currently setting the pace. 
From TalkMarkets
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
Welcome to theCannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock ... 
From Benzinga
50 Biggest Movers From Friday
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 62.7% to close at $3.45 on Friday, reversing from ... 
From Benzinga
Psyched: Cybin Raises CA$45M, Numinus Harvests Legal Mushrooms, Toadstool Enters Psychedelic Space
Cybin Raises CA$45 Million and Heads Towards NEO Exchange This week, Toronto-based Cybin Corp. announced the closing of a private ... 
From Benzinga
Introducing The "Medicinal Mushroom" Stock Index
The enormous potential of medicines based on edible (functional) mushrooms and magic (psychedelic) mushrooms to treat depression, anxiety and addiction health issues has some whispering that... 
From TalkMarkets
How And Why Psychedelic Drugs Can Conquer The Mental Health Crisis
The emerging psychedelic drug industry is thriving. It has attracted a multitude of high-profile investors. 
From TalkMarkets
Mind Cure’s New Medtech Platform Is A Critical Puzzle-Piece
With its new digital therapeutics platform, Mind Cure is positioning itself as an emerging leader in the psychedelic drug industry. 
From TalkMarkets
Why Psychedelic Stocks Are A Strong Hedge Against COVID-19 Risk
Psychedelic stocks offer a robust hedge against COVOD-19 economic risk, but also remain a strong bet once the pandemic recedes. 
From TalkMarkets
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
Welcome to theCannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock ... 
From Benzinga
Will Mindmed Nasdaq Listing Be The Next Sector-Wide Catalyst?
The Compass Pathways IPO sparked a new rally in psychedelic stocks. We expect similar dynamics if MindMed up-lists on the Nasdaq. 
From TalkMarkets
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.